<DOC>
	<DOCNO>NCT02864953</DOCNO>
	<brief_summary>This study evaluate use investigational drug CIRARA versus placebo patient large hemispheric infarction .</brief_summary>
	<brief_title>CIRARA Large Hemispheric Infarction Analyzing Modified Rankin Scale ( mRS ) Mortality ( CHARM )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Brain Edema</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>1 . A clinical diagnosis acute ischemic stroke middle cerebral artery territory 2 . A large lesion define image 3 . Time start infusion study drug ≤ 9 hour time symptom onset 4 . Age ≥ 18 ≤ 85 year 1 . Commitment decompressive craniectomy prior enrollment 2 . Treatment intraarterial recombinant tissue plasminogen activator ( rtPA ) endovascular thrombectomy clot disruption 3 . Evidence concurrent infarction contralateral hemisphere sufficiently serious affect functional outcome 4 . Clinical sign herniation 5 . Brain hemorrhage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>